MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    The Unique Clinical Profile of Dystonia in Parkinson Disease

    L. Xavier, A. Eid, H. Hwang, J. Perlmutter, P. Kotzbauer, M. Campbell, S. Norris (Saint Louis, USA)

    Objective: Characterize clinical features of dystonia and levodopa-related dyskinesias in Parkinson disease (PD). Background: Dystonia affects 30-60% of individuals with PD. [1] Despite recognition as…
  • 2025 International Congress

    The Movement Disorders Society Unified Parkinson Disease Rating Scale Motor Subscore Is Not Associated With Future Parkinson Disease Milestones – an observational study using linked health administrative data

    P. Gros, S. Bronskill, S. Dorrance, X. Wang, M. Chiu, M. Farkouh, C. Marras (Toronto, Canada)

    Objective: To examine the association between time to Parkinson Disease (PD) health administrative data milestones and a one-year change in the Movement Disorders Society –…
  • 2025 International Congress

    Sex specific role of dyslipidemia and statin use in Parkinson’s disease pathogenesis

    K. Tsutsumi, E. Shah, S. Isfahani (Orange, USA)

    Objective: Our aim was to characterize the role of dyslipidemia and statin use in Parkinson’s disease (PD) development, specifically with respect to differences in significance…
  • 2025 International Congress

    A Study of Delayed Specialist Consultation in Parkinson’s Disease Patients in Uzbekistan

    L. Kenjaeva, B. Mukhammedaminov, N. Aripova, Y. Nishonova, G. Kendjaeva (Tashkent, Uzbekistan)

    Objective: Parkinson’s disease (PD) is a progressive neurodegenerative disorder where early diagnosis is crucial for preserving motor function and improving quality of life. However, in…
  • 2025 International Congress

    Study on individual differences in shoulder and hip joints during walking in patients with Parkinson’s disease

    J. Ogawa, Y. Yamaguchi, K. Kakegawa, T. Matsuda, T. Kurayama (Ginza, Chuo-ku, Japan)

    Objective: To analyze the motion characteristics of the shoulder and hip joints during gait in people with Parkinson’s disease (PwP) and explore the classification of…
  • 2025 International Congress

    Dynamics Of Pallidal Beta Activity During Voluntary Movement In Parkinson’s Disease And Cervical Dystonia

    V. Filyushkina, S. Usova, A. Gamaleya, A. Tomskiy, A. Sedov (Moscow, Russian Federation)

    Objective: The aim of the current study was to analyze local field potentials (LFP) recorded from globus pallidus (GP) during voluntary movements in patients with…
  • 2025 International Congress

    Differential Effect of Dopaminergic Treatment on Bradykinesia Features and Limb-kinetic Apraxia in Parkinson’s Disease

    M. de Riggi, G. Paparella, A. Cannavacciuolo, D. Birreci, D. Costa, M. Passaretti, L. Angelini, M. Bologna (Rome, Italy)

    Objective: To investigate the differential effects of dopaminergic therapy on bradykinesia and limb-kinetic apraxia in PD patients using kinematic analysis. Additionally, transcranial magnetic stimulation (TMS)…
  • 2025 International Congress

    Theta-Burst Subthalamic Nucleus Deep Brain Stimulation Enhances Segregation of Cognitive Networks in Parkinson’s Disease

    M. Abu-Zahra, S. Audrain, A. Barnett, K. Wu, W. Choi, K. Jann, C. Mark, R. Briggs, J. Cavaleri, B. Lee, X. Mason, D. Lee (Montreal, Canada)

    Objective: This study investigates the effects of a novel TBS paradigm on large-scale brain network connectivity in PD patients. Background: Parkinson’s disease (PD) is a…
  • 2025 International Congress

    The differential transcriptomic signatures of substantia nigra in Parkinson disease and Multiple system atrophy

    JH. Shin, KE. Ruhno, C. Shin, HJ. Kim, JH. Moon, HJ. Kim (Seoul, Republic of Korea)

    Objective: To investigate transcriptomic signatures of Parkinson's disease (PD) and the Parkinsonian subtype of Multiple System Atrophy (MSA-P) in the substantia nigra pars compacta (SNpc).…
  • 2025 International Congress

    Bayesian Re-Analysis of Phase I and II Subthalamic Nucleus Perfusion Changes Following Mesenchymal Stem Cell Infusion in Parkinson’s Disease

    T. Thomas, T. Ellmore, E. Tharp, J. Martinez-Lemus, C. Green, J. Suescun, C. Onuigbo, T. Le, E. Rodarte Rascon, R. Ritter Iii, M. Schiess (Houston, USA)

    Objective: To compare subthalamic nucleus (STN) perfusion changes following mesenchymal stem cell (MSC) infusion in Parkinson’s disease (PD) using Bayesian methods in both Phase I…
  • « Previous Page
  • 1
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley